DARPA  January 31, 2023 DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program aims to develop a field-deployable, shelf-stable whole blood equivalent that can be used to resuscitate trauma patients when donated blood products are not available. DARPA selected the University of Maryland to lead this effort with support from several universities and industries. Their plan is to integrate multiple bio-artificial and synthetic components to deliver oxygen, stop bleeding, and replace volume—key therapeutic functions of whole blood in resuscitation. They will evaluate efficacy and safety in increasingly complex and realistic trauma models and intend to develop strategies for […]